SynAct Pharma AB (SYNACT.ST)

SEK 9.69

(0.36%)

Annual Income Statements

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 778 Thousand 1.06 Million 88 Thousand - 338.51 Thousand 303.56 Thousand
Gross Profit -778 Thousand -1.06 Million -88 Thousand - -338.51 Thousand -303.56 Thousand
Operating Expenses 224.49 Million 105.7 Million 76.69 Million 31.28 Million 24.8 Million 28.39 Million
Selling, General and Administrative Expenses 33.92 Million 35.61 Million 16.22 Million 8.81 Million 24.22 Million 28.08 Million
Research and Development Expenses 105.05 Million 70.06 Million 60.49 Million 22.78 Million 15.17 Thousand 21.81 Million
Other Expenses 85.51 Million 28 Thousand -16 Thousand -314 Thousand 571.88 Thousand 303.56 Thousand
Cost and Expenses 224.49 Million 105.7 Million 76.69 Million 31.28 Million 24.8 Million 28.39 Million
Operating Income -224.49 Million -105.7 Million -76.69 Million -31.28 Million -24.8 Million -28.39 Million
Interest Expense - 294 Thousand 105 Thousand 39 Thousand 2.38 Million -
Income Tax Expense -8.46 Million -7.86 Million -7.5 Million -4.75 Million -3.14 Million -4.79 Million
Earnings before Tax -224.27 Million -107.06 Million -76.8 Million -31.3 Million -27.1 Million -28.24 Million
Net Income -215.81 Million -99.2 Million -69.3 Million -26.55 Million -23.95 Million -23.44 Million
Earnings Per Share Basic -6.64 -3.60 -2.67 -1.23 -1.62 -1.70
Earnings Per Share Diluted -6.64 -3.60 -2.67 -1.23 -1.62 -1.70
Weighted Average Shares Outstanding 32.52 Million 27.58 Million 25.96 Million 21.65 Million 14.82 Million 13.79 Million
Weighted Average Shares Outstanding (Diluted) 32.52 Million 27.58 Million 25.96 Million 21.65 Million 14.82 Million 13.79 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -222.7 Million -105.7 Million -76.61 Million -30.9 Million -25 Million -27.94 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts